Baxter International | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Abbott USD 8.7B 363M 2025-03
AtriCure USD 129.57M 9.23M 2025-03
Avanos Medical USD 598.1M 439.7M 2024-12
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Boston Scientific USD 3.74B 144M 2025-03
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 924.6M 82.4M 2024-12
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Fresenius EUR 5.16B 287M 2024-12
Globus Medical USD 597.02M 19.41M 2024-12
Halozyme Therapeutics USD 122.51M 4.38M 2024-12
ICU Medical USD 592.11M 11.22M 2024-12
Insulet USD 488.2M 32.4M 2024-12
Integra LifeSciences USD 407.42M 18.45M 2024-12
Intuitive Surgical USD 1.68B 3.3M 2025-03
J&J USD 8.26B 10.37B 2025-03
Laboratory Of America USD 3.01B 100.2M 2025-03
Masimo USD 959.8M 485.3M 2024-12
Medtronic USD 6.65B 162M 2025-01
Merit Medical Systems USD 314.32M 4.28M 2025-03
Quest Diagnostics USD 2.31B 46M 2025-03
Smith & Nephew USD 2.65B 155M 2024-12
Stryker USD 5.86B 1.45B 2024-12
Tandem Diabetes Care USD 355.3M 72.07M 2025-03
Teleflex USD 570.34M 335.45M 2025-03
Terumo JPY 217.77B 10.36B 2024-12
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Baxter International Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.